GlassScriptPhysician profile
Kunal J Teli
NPI 1295041671
$6,708.10
in general payments reported to CMS, 2019-2025
27 companies · $561 in 2025
The $561 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $759 · 2021: $1,020 · 2022: $302 · 2023: $2,180 · 2024: $806 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,424 · Travel and Lodging: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,424.35 |
| Travel and Lodging | $1,122.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,988.21 | 2021-2023 | Venaseal |
| Abiomed | $971.65 | 2022-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $796.89 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $338.60 | 2024-2025 | Assure Wcd |
| Abbott Laboratories | $304.36 | 2022-2025 | Jot Dx, Diamondback Coronary, Ensite Precision |
| Novartis Pharmaceuticals Corporation | $291.19 | 2019-2020 | |
| Boston Scientific Corporation | $284.88 | 2019-2021 | |
| Shockwave Medical, INC | $240.88 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $191.00 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $178.13 | 2019-2021 | |
| Medtronic Vascular, INC. | $153.54 | 2020 | |
| Cardiovascular Systems INC. | $143.31 | 2022-2023 | Diamondback Coronary |
| E.R. Squibb & Sons, L.L.C. | $135.70 | 2024-2025 | Camzyos, Eliquis |
| Pfizer INC. | $115.02 | 2019-2023 | |
| Glaxosmithkline, LLC. | $87.74 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $78.10 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Philips North America LLC | $71.64 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.19 | 2023 | Jardiance |
| Amarin Pharma, INC. | $62.83 | 2020 | |
| Novo Nordisk INC | $50.49 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $38.46 | 2019 | |
| Lilly USA, LLC | $30.86 | 2019 | |
| Hikma Pharmaceuticals USA | $29.70 | 2019 | |
| Biotronik INC. | $19.85 | 2019 | |
| Merck Sharp & Dohme LLC | $14.88 | 2019 | |
| Bardy Diagnostics, INC. | $12.00 | 2020 | |
| Medicomp INC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Teli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.